“IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE”, FMHR, vol. 4, no. 3, pp. 4646–4654, Mar. 2026, Accessed: Nov. 08, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3859